CXCR2 inhibition suppresses acute and chronic pancreatic inflammation von Steele, Colin W, Karim, Saadia A, Foth, Mona, Rishi, Loveena, Leach, Joshua DG, Porter, Ross J, Nixon, Colin, Jeffry Evans, TR, Carter, C Ross, Nibbs, Robert JB, Sansom, Owen J, Morton, Jennifer P

Volltext

Antiproliferative effect of exemestane in lung cancer cells von Koutras, Angelos, Giannopoulou, Efstathia, Kritikou, Ismini, Antonacopoulou, Anna, Evans, T R Jeffry, Papavassiliou, Athanasios G, Kalofonos, Haralabos

Volltext

Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine von Conway, James Rw, Herrmann, David, Evans, Tr Jeffry, Morton, Jennifer P, Timpson, Paul

Volltext

Drug Insight: cancer cell immortality-telomerase as a target for novel cancer gene therapies von Keith, W Nicol, Bilsland, Alan, Hardie, Maryon, Evans, TR Jeffry

Volltext

mTORC2 Signaling Drives the Development and Progression of Pancreatic Cancer von Driscoll, David R, Karim, Saadia A, Sano, Makoto, Gay, David M, Jacob, Wright, Yu, Jun, Mizukami, Yusuke, Gopinathan, Aarthi, Jodrell, Duncan I, Evans, T R Jeffry, Bardeesy, Nabeel, Hall, Michael N, Quattrochi, Brian J, Klimstra, David S, Barry, Simon T, Sansom, Owen J, Lewis, Brian C, Morton, Jennifer P

Volltext

New approaches in the management of advanced breast cancer - role of combination treatment with liposomal doxorubicin von Macpherson, Iain Rj, Evans, Tr Jeffry

Volltext

A phase I study of intravenous and oral rucaparib in combination with chemotherapy in patients with advanced solid tumours von Wilson, Richard H, Evans, TR Jeffry, Middleton, Mark R, Molife, L Rhoda, Spicer, James, Dieras, Veronique, Roxburgh, Patricia, Giordano, Heidi, Jaw-Tsai, Sarah, Goble, Sandra, Plummer, Ruth

Volltext

Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours von Jones, Robin L., Ratain, Mark J., O'Dwyer, Peter J., Siu, Lillian L., Jassem, Jacek, Medioni, Jacques, DeJonge, Maja, Rudin, Charles, Sawyer, Michael, Khayat, David, Awada, Ahmad, de Vos-Geelen, Judith M.P.G.M., Evans, T.R. Jeffry, Obel, Jennifer, Brockstein, Bruce, DeGreve, Jacques, Baurain, Jean-Francois, Maki, Robert, D'Adamo, David, Dickson, Mark, Undevia, Samir, Geary, David, Janisch, Linda, Bedard, Philippe L., Abdul Razak, Albiruni R., Kristeleit, Rebecca, Vitfell-Rasmussen, Joanna, Walters, Ian, Kaye, Stan B., Schwartz, Gary

Volltext

Plasma N-acetyl-glucosaminidase in advanced gastro-intestinal adenocarcinoma correlates with age, stage and outcome von Hartmann, Daniel, von Figura, Guido, Song, Zhangfa, Harden, Sharon, Scott, Lucy C, Evans, T R Jeffry, Rudolph, Karl Lenhard, Bilsland, Alan E, Keith, W Nicol

Volltext

The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy von Reader, Claire S, Vallath, Sabari, Steele, Colin W, Haider, Syed, Brentnall, Adam, Desai, Ami, Moore, Kate M, Jamieson, Nigel B, Chang, David, Bailey, Peter, Scarpa, Aldo, Lawlor, Rita, Chelala, Claude, Keyse, Stephen M, Biankin, Andrew, Morton, Jennifer P, Evans, TR Jeffry, Barry, Simon T, Sansom, Owen J, Kocher, Hemant M, Marshall, John F

Volltext

Abstract CT140: NUC-3373, a targeted inhibitor of thymidylate synthase, in patients with advanced colorectal cancer von Kazmi, Farasat, Ciombor, Kristen, Graham, Janet, Coveler, Andrew, Myers, Michelle, Berlin, Jordan, Harrison, David, Blagden, Sarah, Evans, TR Jeffry

Volltext

Measuring patient-reported outcomes in advanced gastric cancer von Xu, Jianming, Evans, Tr Jeffry, Coon, Cheryl, Copley-Merriman, Kati, Su, Yun

Volltext

Relationship between clinical efficacy and AEs of IMCgp100, a novel bispecific TCR–anti-CD3, in patients with advanced melanoma von Middleton, Mark R., Steven, Neil Matthew, Evans, TR Jeffry, Infante, Jeffrey R., Sznol, Mario, Hamid, Omid, Shoushtari, Alexander Noor, Anthoney, Alan, Gupta, Avinash, Woodcock, Victoria K, Easton, Rachael, Corrie, Philippa Gail

Volltext

Pharmacodynamic effect of IMCgp100 (TCR–CD3 bispecific) on peripheral cytokines and association with overall survival in patients with advanced melanoma von Middleton, Mark R., Steven, Neil Matthew, Evans, TR Jeffry, Infante, Jeffrey R., Hamid, Omid, Shoushtari, Alexander Noor, Corrie, Philippa Gail, Anthoney, Alan, Gupta, Avinash, Woodcock, Victoria K, McAlpine, Cheryl, Sznol, Mario

Volltext

Irreversible ototoxicity associated with the use of erlotinib in a patient with pancreatic cancer von Koutras, Angelos K., Mastronikolis, Nicholas S., Jeffry Evans, Tr, Papadeas, Evangelos S., Makatsoris, Thomas, Kalofonos, Haralabos P.

Volltext

Phase 1/2a study of once daily oral BAL101553, a novel tumor checkpoint controller (TCC), in adult patients with progressive or recurrent glioblastoma (GBM) or high-grade glioma von Lopez, Juanita Suzanne, Kristeleit, Rebecca Sophie, Rulach, Robert, Haris, Noor Md, Scaranti, Mariana, Mulholland, Paul James, Crawford, Donna, Bashir, Saira, Aversa, Caterina, Hannah, Alison L., Anderson, Stephanie, Engelhardt, Marc, Kaindl, Thomas, Larger, Patrice, McKernan, Phil, Evans, TR Jeffry, Plummer, Elizabeth

Volltext

Abstract P3-13-04: Efficacy and safety of eribulin in combination with capecitabine in patients with metastatic breast cancer: an open-label, phase II dose-confirmation study von Twelves, Chris, Nasim, Muhammad Y, Anthoney, Alan, Savulsky, Claudio I, Yin, Shuxin, Evans, TR Jeffry

Volltext

Abstract C032: NUC-7738 in combination with pembrolizumab in patients with metastatic melanoma: Phase 2 results from the NuTide:701 study von Blagden, Sarah P, Symeonides, Stefan N, Skolariki, Aglaia, Haris, Noor Md, Boh, Zhuang, Um, In Hwa, Elshani, Mustafa, Dickson, Alison L, Zhang, Ying, Harrison, David J, McKissock, Fiona G, Oelmann, Elisabeth, Bloss, Jeffrey D, Cook, Natalie, Evans, TR Jeffry, Plummer, E. Ruth

Volltext

Abstract B049: Phase II study of NUC-3373, leucovorin, irinotecan (NUFIRI) + bevacizumab vs FOLFIRI + bevacizumab for the second-line treatment of patients with advanced/metastatic... von Wilson, Richard H, Ciombor, Kristen K, Coveler, Andrew L, Graham, Janet S, Schlechter, Benjamin L, George, Thomas J, Élez, Elena, Evans, TR Jeffry, Berlin, Jordan, de Gramont, Aimery, McKissock, Fiona G, Oelmann, Elisabeth, Bloss, Jeffrey D, Martini, Giulia, Bennouna, Jaafar, Modest, Dominik P, Taieb, Julien, Tabernero, Josep

Volltext

Telomerase-directed molecular therapeutics von Keith, W. Nicol, Bilsland, Alan, Evans, T.R. Jeffry, Glasspool, Rosalind M.

Volltext